Cardiovascular

Impact of Coronary Microvascular Dysfunction on Left Ventricular Function After Percutaneous Coronary Intervention: Assessment With Combined Dipyridamole-Exercise Stress and Myocardial Strain/Work.

TL;DR

Combined dipyridamole-exercise stress echocardiography with myocardial strain/work analysis effectively evaluates LV function in CMD, with decreased CFVR post-PCI associated with impaired LV function and worse 1-year quality of life outcomes.

Key Findings

Patients with CMD (CFVR < 2.5) showed impaired LV functional reserve compared to those with CFVR ≥ 2.5 after PCI.

  • 84 CAD individuals who underwent left anterior descending artery PCI were enrolled (54 ± 10 years, 17.9% female).
  • Participants were stratified into CFVR ≥ 2.5 group (n = 63) and CFVR < 2.5 group (n = 21).
  • The CFVR < 2.5 group showed lower GLS, GWI, and GWE at peak exercise and recovery (all p < 0.05).
  • The CFVR < 2.5 group showed lower peak exercise GCW and higher recovery GWW (all p < 0.05).
  • Smaller absolute changes ΔE-R in GLS, GWI, and GCW were observed in the CFVR < 2.5 group (all p < 0.05).

Peak exercise GCW, recovery GWW, and ΔGCW (E-R) were independent predictors of CMD in multivariable analysis.

  • Multivariable analysis identified three independent predictors of CMD: peak exercise global constructive work (GCW), recovery global wasted work (GWW), and ΔGCW (E-R).
  • These parameters reflect differences before versus after exercise stress.
  • All predictors were derived from the combined dipyridamole-exercise stress echocardiography assessment at 3 months post-PCI.

At 1-year follow-up, the CFVR ≥ 2.5 group had significantly better quality of life outcomes on the Seattle Angina Questionnaire compared to the CFVR < 2.5 group.

  • SAQ physical limitation score was higher in the CFVR ≥ 2.5 group (92.86 ± 11.38 vs. 82.14 ± 17.93, p < 0.05).
  • SAQ quality of life score was higher in the CFVR ≥ 2.5 group (95.63 ± 10.57 vs. 83.33 ± 19.90, p < 0.05).
  • SAQ summary score was higher in the CFVR ≥ 2.5 group (94.05 ± 8.51 vs. 85.71 ± 15.71, p < 0.05).
  • No adverse clinical events occurred in either group at 1-year follow-up.

Combined dipyridamole-exercise stress echocardiography (DExE) with myocardial strain/work analysis was used to assess CMD and LV function at 3 months post-PCI.

  • This was a prospective study enrolling CAD individuals who underwent left anterior descending artery PCI.
  • DExE assessment was performed at 3 months post-PCI to evaluate myocardial strain/work parameters at rest and stress.
  • The primary endpoint was adverse clinical events and the secondary endpoint was SAQ health status at 1 year.
  • CMD was defined by coronary flow velocity reserve (CFVR) < 2.5.

CMD persists after PCI in individuals with coronary artery disease and is associated with impaired LV functional reserve detectable by stress echocardiography.

  • 21 of 84 participants (25%) had CFVR < 2.5 at 3 months post-PCI, indicating persistent CMD.
  • The study underscores the need for close cardiac function monitoring in post-PCI CMD individuals.
  • Myocardial strain and work parameters captured differences in LV function that were not apparent at rest alone.

Have a question about this study?

Citation

Zhao W, Dong X, Ji X, Tang J, Ding L, Zhou Y, et al.. (2026). Impact of Coronary Microvascular Dysfunction on Left Ventricular Function After Percutaneous Coronary Intervention: Assessment With Combined Dipyridamole-Exercise Stress and Myocardial Strain/Work.. Echocardiography (Mount Kisco, N.Y.). https://doi.org/10.1111/echo.70419